Skip to main content
Search

# MobGen

1 related articles

Subscribe to updates
  1. bioRxiv

    No trillion-sequence library needed: MobGen designs monobodies from scratch that bind SARS-CoV-2 RBD and neutralize B.1

    Monobodies, small binding proteins derived from a human fibronectin type III domain, previously required screening libraries of 3×1013 random sequences by phage display to find high-affinity binders against a viral antigen. MobGen chains RFdiffusion, AlphaFold2 backpropagation and ProteinMPNN into one computational pipeline; targeting the SARS-CoV-2 B.1 spike receptor-binding domain it generated 11,450 sequences, yielded 7 binders, and one of them neutralized B.1 pseudovirus at micromolar potency. Adding a C-terminal tail raised production about 7-fold on average and binding affinities reached 22.1–424.8 nM, but neutralization stayed around 2–25 µM and no monobody covered all tested variants.

You’re all caught up